Erratum

Foley JE, Sreenan S. Efficacy and Safety Comparison Between the DPP-4 Inhibitor Vildagliptin and the Sulfonylurea Gliclazide After Two Years of Monotherapy in Drug-naïve Patients with Type 2 Diabetes. Horm Metab Res 2009; 41: 905–909

In the original article Figure 2 was incorrect. In the line graph, the baseline data (at week 0) for HbA_1c were missing. The corrected figure is provided below. This mistake does not affect the remaining content of the article.

This article is an erratum to 905 in: Journal of HMR, Issue 12, 2009 .